rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Connect Biopharma Holdings Limited -

CNTB · Nasdaq

Health CareBiotechnologyNot moving yet

CNTB stood above a rising 150-day average in 29 of the last 52 weekly readings, and has been out of that trend for the last 20 weeks. It is 58.5% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 20
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$8.7M
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
55 (+19)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 29 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$7.7MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months2
Sale orders, 12 months0
Buyers · sellers1 · 0
WhoDidSharesTraded
James HuangDirectorbought150,000at $2.4829 May 2026filed 2 Jun 2026
James HuangDirectorbought1,160,000at $3.4531 Mar 2026filed 1 Apr 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders55+19 on the quarter
New · exited26 · 7
Reported value$33.2M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Ikarian Capital, LLCreduced · filed 14 Aug 20264,538,534$10.8M-849,952−15.8%
683 Capital Management, LLCadded · filed 14 Aug 20261,285,000$3.1M+385,000+42.8%
BOOTHBAY FUND MANAGEMENT, LLCreduced · filed 14 Aug 2026973,732$2.3M-260,850−21.1%
BlackRock, Inc.new · filed 7 Aug 2026871,653$2.1M+871,653
PERCEPTIVE ADVISORS LLCunchanged · filed 14 Aug 2026792,696$1.9M00.0%
ADAR1 Capital Management, LLCreduced · filed 14 Aug 2026700,000$1.7M-42,400−5.7%
BML Capital Management, LLCadded · filed 7 Aug 2026573,287$1.4M+164,400+40.2%
SILVERARC CAPITAL MANAGEMENT, LLCnew · filed 13 Aug 2026545,000$1.3M+545,000
Richmond Brothers, Inc.added · filed 11 Aug 2026535,612$1.3M+59,028+12.4%
Knott David M Jradded · filed 12 Aug 2026444,862$1.1M+57,027+14.7%
31 Mar 2023 – 30 Jun 2026
113253Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Jean I. Liu Company insiderDirector · last 30 Sep 20260 · 0
Kleanthis Gabriel Xanthopoulos Company insiderDirector · last 30 Sep 20260 · 0
James Huang Company insiderDirector · last 29 May 20262 · 0

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-137%
Share count trendFY 2025 · to 26 Mar 20260.1%
Cash and equivalentsFY 2025 · to 31 Dec 2025$38.3M
Free cash flowFY 2025 · to 31 Dec 2025−$51.6M

Analyst forecasts

No analyst forecasts yet.